switching from semaglutide to liraglutide Tirzepatide: A Provider's Guide Liraglutide vs Semaglutide vs GLP-1
Description
Semaglutide 2.4 mg (Wegovy) is currently NICE-approved for use within specialist NHS weight management services under specific eligibility criteria, and is also available privately
Ratajczak, J
Eligibility is selective, with strict BMI, age, comorbidity, and previous-treatment criteria, and some participants receive placebo
Tirzepatide went into shortage within months of the Zepbound launch
